LEADER 01188nam 2200397 450 001 9910821901803321 005 20230817191138.0 010 $a1-78064-526-0 035 $a(CKB)4100000007332653 035 $a(MiAaPQ)EBC5622039 035 $a(EXLCZ)994100000007332653 100 $a20190115d2019 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aParthenium weed $ebiology, ecology and management /$fedited by Steve Adkins, Asad Shabbir and Kunjithapatham Dhileepan 210 1$aWallingford, Oxfordshire ;$aBoston, MA :$cCABI,$d[2019] 210 4$dİ2019 215 $a1 online resource (337 pages) 225 1 $aCABI invasive species series ;$v11 410 0$aCABI invasive species series ;$v11. 606 $aParthenium$xControl 615 0$aParthenium$xControl. 676 $a632.52 702 $aAdkins$b Steve 702 $aShabbir$b Asad 702 $aDhileepan$b Kunjithapatham 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910821901803321 996 $aParthenium weed$92747396 997 $aUNINA LEADER 02936oam 2200445Mn 450 001 9910154926203321 005 20240501163441.0 010 $a0-429-58633-7 010 $a0-429-16002-X 010 $a1-4822-3622-2 035 $a(CKB)4340000000018242 035 $a(MiAaPQ)EBC4746880 035 $a(OCoLC)1080588888 035 $a(OCoLC-P)1080588888 035 $a(FlBoTFG)9780429160028 035 $a(EXLCZ)994340000000018242 100 $a20190103d2017 uy 0 101 0 $aeng 135 $aur|n||||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 00$aADVERSE DRUG INTERACTIONS $ea handbook for prescribers 205 $aSecond edition. 210 $a[Place of publication not identified]$cCRC Press$d2017 215 $a1 online resource (1,214 pages) 311 $a1-138-45713-2 311 $a1-4822-3621-4 327 $aCover -- Half Title -- Title Page -- Copyright Page -- Table of Contents -- Acknowledgments -- Abbreviations -- Preface -- Easy Reference Guide to Drugs -- Introduction -- Drug Metabolism and Elimination -- Individual Variability of Adverse Drug Interactions -- Pathological States That Are Associated with Increased Risk of Adverse Drug Interactions -- Special Populations at Higher Risk of Adverse Drug Interactions -- Specific Clinical Problems -- Editors -- Contributors -- Part 1: Drugs Acting on the Cardiovascular System -- Part 2: Drugs Acting on the Central Nervous System -- Part 3: Anticancer and Immunomodulating Drugs -- Part 4: Anticoagulants -- Part 5: Antidiabetic Drugs -- Part 6: Other Endocrine Drugs -- Part 7: Analgesics -- Part 8: Musculoskeletal Drugs -- Part 9: Anesthetic Drugs -- Part 10: Drugs to Treat Infections -- Part 11: Drugs Acting on the Gastrointestinal Tract -- Part 12: Respiratory Drugs -- Part 13: Metabolic Drugs -- Part 14: Obstetrics and Gynecology -- Part 15: Drugs Used to Treat the Urinary System -- Part 16: Drugs of Abuse -- Part 17: Miscellaneous -- Part 18: Over-the-Counter/Online Drugs and Remedies -- Appendix A: Factors Associated with Drug Effects -- Appendix B: Factors Associated with Interactions -- Appendix C: Foods Implicated in Potentially Severe Interactions -- Appendix D: Clinical Drug Development -- Appendix E: Assessments of Manifestations of DDIs -- Appendix F: Triptan Sensations -- Appendix G: Assessment of Severity of Liver Disease -- Appendix H: Prescribing Guidelines for Elderly Patients -- Appendix I: Factors Affecting Efficacy of Anti-Infective Agents -- Appendix J: Assessments of Obesity. 606 $aDrugs$xSide effects$vHandbooks, manuals, etc 606 $aDrug interactions$vHandbooks, manuals, etc 615 0$aDrugs$xSide effects 615 0$aDrug interactions 676 $a615.7/045 801 0$bOCoLC-P 801 1$bOCoLC-P 906 $aBOOK 912 $a9910154926203321 996 $aADVERSE DRUG INTERACTIONS$92800726 997 $aUNINA